Roundtable Report Highlights Importance of Immunizing Canada’s Caregivers Against Influenza, Identifying Challenges and Opportunities to Protect This Critical Group

Experts agreed that caregivers are essential to the Canadian healthcare system and economy, yet their importance often goes underrecognized, even by caregivers themselves.

New York, NEW YORK (June 1, 2022)—The Global Coalition on Aging (GCOA) today released a report summarizing key insights from an expert roundtable on vaccinating Canada’s caregivers against influenza. The roundtable, held virtually, brought together leading Canadian health policy experts, family caregivers, patient advocacy groups, aging experts, and other thought leaders to discuss challenges and strategies to reach this critically important yet hard-to-reach group.

Around 8 million Canadians provide care to a family member or friend, many of whom are medically vulnerable. At the same time, only 42% of Canadian adults received an influenza vaccine during the two seasons prior to the start of the COVID-19 pandemic, with the full impact of influenza widely underrecognized. Research shows that a case of influenza leads to a tenfold increase in the risk of a first heart attack and an eightfold increase in stroke risk in the few days following an infection.

“Influenza can have a devastating impact,” explained Michael Hodin, CEO of the Global Coalition on Aging.Each year, influenza increases hospital admissions and overcrowds emergency departments, creating unsafe conditions and crippling the healthcare system, while leading to a cascade of decline in many previously healthy adults. Vaccination is one of the most cost-effective and accessible ways that caregivers can protect their own health as well as that of their loved one. Yet, too few Canadian adults, caregivers included, are immunizing themselves against influenza and other preventable diseases.”

Among the top insights uncovered at the roundtable were the centrality of caregivers to the health and wellbeing of families, to the efficient functioning of the Canadian healthcare system, and to the Canadian economy overall. At the same time, the importance of caregivers – and the risks posed to them by infectious diseases like influenza – has largely gone underrecognized across the system and even by caregivers themselves.

The COVID-19 pandemic brought both caregivers and vaccination to the forefront of national and global attention, yet, the expert discussion revealed, the pandemic has also made it more difficult to adequately support caregivers and identify them as partners in care.

Another important insight from the roundtable was a lack of self-recognition among many of Canada’s 8 million caregivers as “caregivers” and as individuals whose own health status is vital and vulnerable, nor awareness of what steps to take to protect their health.

In addition to a need for more nuanced and targeted communications, experts at the roundtable pointed to an opportunity now to bolster existing access points and create new ones, building on innovations and policy momentum from COVID-19 vaccination initiatives. “Access is key for vaccine coverage,” said Laura Tamblyn Watts, President and CEO of CanAge. “As we’ve seen during COVID-19, we need to make sure that people can get their flu vaccines not just in healthcare settings such as doctors’ offices, pharmacies, and long-term care, but also in workplaces and the communities. Our CanAge Vaccine Report shows clearly that access to flu vaccines depends on your province and in some cases, postal code.”

Experts at the GCOA roundtable called for three critical actions:

  • Collect evidence on the burden and cost of influenza on caregivers, the Canadian healthcare system and society and identify best practices that can reduce the burden.
  • Expand access to vaccines, including where vaccines can be administered and by whom, engaging employers in this effort.
  • Develop wide-reaching and targeted education materials in which caregivers can recognize themselves.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.